Heart transplant pathology
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Heart transplant pathology is a niche in cardiac pathology.
Overview - table
Types of rejection[1]
Type (grade) | Description | Details | Image |
antibody-mediated rejection (acute vascular) | edema, dilated small vessels | scant inflammation | acute |
normal (0R) | normal | no extravascular monocytes | |
acute cellular (1R) | (perivascular) inflammatory infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmacytic), scant damage | mild cellular |
acute cellular (2R) | (perivascular) inflammatory space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmacytic), obvious damage (myocyte eosinophilia or drop-out) | mod. cellular, mod. cellular resolving |
acute cellular (3R) | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss/damage | |
chronic | concentric intimal thicking | internal elastic lamina preserved (unlike atherosclerosis) | chronic, chronic |
Pitfalls[1]
Name | Description | Details | Image |
Quilty effect | endocardial/subendocardial B-lymphocytes (in clusters) | may extend into myocardium, not assoc. with blood vessels +/-myocyte damage; benign behaviour clinically | Quilty effect, Quilty effect |
Old biopsy site | hemosiderin-laden macrophages | fibrosis/myocyte replacement | old Bx site |
Mimics
Biopsy site reaction
General
- Can be confused for rejection.
Microscopic
Features:
- Hemosiderin-laden macrophages.
- +/-Fibrosis/myofibre loss-replacement.
- +/-Scant inflammatory infiltration.
Image: Biopsy site (pathconsultddx.com).
Quilty effect
General
- Can be confused for rejection.
- Benign behaviour.
Trivia:
- The name Quilty comes from the patient in which this was first recognized.
Microscopic
Features:[3]
- Lymphocytes in clusters (B cells and T cells).
- Associated with the endocardium ("endothelium of the heart"), i.e. on the surface - key feature.
- Often have capillaries in centre; usu. not associated with large blood vessels.
- Lymphocytes separated by collagen.
Notes:
- No longer subclassified.[2]
- Traditional classification (by location):
- Quilty A: Endocardial/subendocardial.
- Quilty B: Endocardial/subendocardial + myocardium.
- +/-Myocyte damage.[4]
- Traditional classification (by location):
Images:
IHC
Mix of T cell and B cells:[3]
- CD3 +ve.
- CD20 +ve.
Notes:
- ACR is T cells.[3]
Coronary atherosclerosis (ischemic injury)
General
- Usu. early - related to atherosclerosis in the donor heart.
- Not typically biopsied. (???)
Microscopic
Features:
- Findings seen in atherosclerosis.
Rejection
It comes in different flavours:[5]
- Antibody-mediated rejection (acute vascular rejection).
- Acute cellular rejection.
- Chronic rejection.
Antibody-mediated rejection
- Abbreviated as AMR.
General
Microscopic
Features:[7]
- Edema.
- Dilated small vessels.
- Scant inflammatory infiltrate.
- Macrophage margination.[8] (???)
Image:
IHC
Features:[2]
- C4d.
- C3d.
Acute cellular rejection
General
- Common form of rejection.
Microscopic
Features:
- Perivascular lymphocytic infiltrate, usu. deep.
- Reactive endothelium.
- +/-Myocardial eosinophilia.
- +/-Expansion of perivascular space.
Notes:
- The main DDx is a Quilty lesion - these are attached to the surface and are typically not associated with a blood vessel.
Grading - comparison
Grading scheme 2004/1990:[9]
Grade 2004 | Grade 1990 | Description | Details | Image |
0R | 0 | normal | no extravascular monocytes | |
1R | 1A | infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmic), scant damage | mild |
1R | 1B | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), focal damage | |
1R | 2 | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), obvious damage | |
2R | 3A | space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmic), obvious damage | mod., mod. resolving |
3R | 3B | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), obvious damage | |
3R | 4 | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss |
Chronic rejection
General
- AKA transplant arteriopathy or cardiac allograft vasculopathy.
- Thought to be a form of accelerated atherosclerosis.[10]
Microscopic
Features:[11]
- Concentric intimal thickening.
- Preservation of internal elastic lamina.
Images:
Notes:
- Morphologically vaguely similar to atherosclerosis.
Other
Post-transplant lymphoproliferative disorder
Main article: Post-transplant lymphoproliferative disorder
- Abbreviated PTLD.
General
Microscopic
Features:
- Large cell lymphoma - see DLBCL.
See also
References
- ↑ 1.0 1.1 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136-7. ISBN 978-0781765275.
- ↑ 2.0 2.1 2.2 2.3 Tan CD, Baldwin WM, Rodriguez ER (August 2007). "Update on cardiac transplantation pathology". Arch. Pathol. Lab. Med. 131 (8): 1169–91. PMID 17683180.
- ↑ 3.0 3.1 3.2 URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 8 March 2011.
- ↑ Winters GL (March 1997). "The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection". Curr. Opin. Cardiol. 12 (2): 146–52. PMID 9192483.
- ↑ URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 9 Febraury 2011.
- ↑ Olsen SL, Wagoner LE, Hammond EH, et al. (1993). "Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations". J. Heart Lung Transplant. 12 (2): S135–42. PMID 8476883.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4. Accessed on: 7 January 2011.
- ↑ Lee CY, Lotfi-Emran S, Erdinc M, et al. (November 2007). "The involvement of FcR mechanisms in antibody-mediated rejection". Transplantation 84 (10): 1324–34. doi:10.1097/01.tp.0000287457.54761.53. PMID 18049118.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136. ISBN 978-0781765275.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 137. ISBN 978-0781765275.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5. Accessed on: 7 January 2011.
- ↑ URL: http://newsroom.ucla.edu/portal/ucla/ucla-team-uncovers-mechanism-behind-179330.aspx. Accessed on: 7 January 2011.
- ↑ URL: http://emedicine.medscape.com/article/431364-overview. Accessed on: 10 February 2011.